A groundbreaking development in the fight against Amyotrophic Lateral Sclerosis (ALS) has emerged from a collaborative effort between the University of St Andrews, the University of Copenhagen, and Drexel University. These institutions have successfully created AI computational models that can predict the degeneration of neural networks in ALS, a devastating disease affecting approximately 200 individuals in Scotland each year.
Published in the esteemed Neurobiology of Disease journal, this research opens up new avenues for exploring disease progression and treatment strategies. It suggests that computational modeling can complement traditional animal and in vitro methods, offering a more comprehensive understanding of ALS.
But here's where it gets controversial: the study challenges the sole reliance on animal models, which have been the primary method for studying ALS. By simulating disease progression and treatment responses in biologically plausible neural networks, researchers can gain insights into the complex dynamics of ALS without the limitations of time and cost constraints associated with animal experiments.
And this is the part most people miss: the neural networks used in this study are not your typical AI models. They communicate using spike signals, mimicking the behavior of nerve cells in our nervous system. This biological plausibility allows researchers to model ALS based on the known structure and connections of cells in the spinal cord.
The models, developed by experts from the School of Psychology and Neuroscience, are intricate systems of mathematical equations. They calculate the excitability of each neuron, simulating how information is passed along the network. By removing neurons and reducing connections in affected populations, the models can predict disease progression and test treatment strategies.
Co-author BeckStrohmer, a postdoctoral researcher from the University of Copenhagen, emphasizes the importance of these models in understanding ALS: "During ALS, neurons die, and communication breaks down. Our models replicate this by removing neurons and reducing connections. This allows us to simulate disease progression and test treatment strategies by saving neurons or strengthening communication."
Dr. Ilary Alodi, a Reader at the St Andrews School of Psychology and Neuroscience, adds: "While models generate hypotheses, they must be tested on animal models due to the complexity of biological systems. In this study, we predicted that our treatment strategy would save a specific neuron population, and our findings in treated mice supported this hypothesis."
So, what does this mean for the future of ALS research? Results like these demonstrate the value of computational models in guiding experimental research. They offer a more refined approach to animal experimentation, helping researchers pinpoint the exact areas and timepoints to focus on.
Dr. Alodi concludes: "We're now applying these models to specific brain areas to understand how neuronal communication changes during dementia. It's an exciting new direction for our lab, and we believe it has the potential to revolutionize our understanding of neurodegenerative diseases."
This research not only advances our understanding of ALS but also opens up new possibilities for treating and managing this devastating disease. It's a step forward in the ongoing battle against neurodegenerative disorders, offering hope and a more targeted approach to finding effective treatments.
